GAMMA THERAPEUTICS, INC.

Basic Information

2611 SW 3RD AVE, STE 280P
PORTLAND, OR, 97201-4957

Company Profile

n/a

Additional Details

Field Value
DUNS: 832408491
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Venous Thromboembolism Risk Marker Assay

    Amount: $1,048,970.00

    DESCRIPTION (provided by applicant): The application's broad, long-term objectives are to develop a rapid, high-throughput clinical assay for 3' fibrinogen that will be used to assess the ri ...

    SBIR Phase II 2011 Department of Health and Human Services
  2. Venous Thromboembolism Risk Marker Assay

    Amount: $514,223.00

    DESCRIPTION (provided by applicant): The application's broad, long-term objectives are to develop a rapid, high-throughput clinical assay for 3' fibrinogen that will be used to assess the risk of a pa ...

    SBIR Phase I 2010 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government